ATE440821T1 - Isochinolinderivate als mao-b inhibitoren - Google Patents

Isochinolinderivate als mao-b inhibitoren

Info

Publication number
ATE440821T1
ATE440821T1 AT03725018T AT03725018T ATE440821T1 AT E440821 T1 ATE440821 T1 AT E440821T1 AT 03725018 T AT03725018 T AT 03725018T AT 03725018 T AT03725018 T AT 03725018T AT E440821 T1 ATE440821 T1 AT E440821T1
Authority
AT
Austria
Prior art keywords
mao
inhibitors
isoquinoline derivatives
isoquinoline
derivatives
Prior art date
Application number
AT03725018T
Other languages
English (en)
Inventor
Andrea Cesura
Sarmiento Rosa Maria Rodriguez
Michelangelo Scalone
Andrew Thomas
Rene Wyler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE440821T1 publication Critical patent/ATE440821T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AT03725018T 2002-04-26 2003-04-14 Isochinolinderivate als mao-b inhibitoren ATE440821T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02009253 2002-04-26
PCT/EP2003/003845 WO2003091219A1 (en) 2002-04-26 2003-04-14 Isoquinoline derivatives

Publications (1)

Publication Number Publication Date
ATE440821T1 true ATE440821T1 (de) 2009-09-15

Family

ID=29265896

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03725018T ATE440821T1 (de) 2002-04-26 2003-04-14 Isochinolinderivate als mao-b inhibitoren

Country Status (30)

Country Link
US (1) US6818774B2 (de)
EP (1) EP1501804B1 (de)
JP (1) JP4322685B2 (de)
KR (1) KR100681585B1 (de)
CN (1) CN1310890C (de)
AR (1) AR039651A1 (de)
AT (1) ATE440821T1 (de)
AU (1) AU2003227614B2 (de)
BR (1) BR0309562A (de)
CA (1) CA2483461C (de)
DE (1) DE60328978D1 (de)
DK (1) DK1501804T3 (de)
ES (1) ES2329354T3 (de)
GT (1) GT200300095A (de)
HR (1) HRP20040952A2 (de)
IL (1) IL164677A0 (de)
MX (1) MXPA04010537A (de)
MY (1) MY133527A (de)
NO (1) NO20044571L (de)
NZ (1) NZ535885A (de)
PA (1) PA8572001A1 (de)
PE (1) PE20040594A1 (de)
PL (1) PL373697A1 (de)
PT (1) PT1501804E (de)
RU (1) RU2318812C2 (de)
SI (1) SI1501804T1 (de)
TW (1) TWI278451B (de)
UY (1) UY27786A1 (de)
WO (1) WO2003091219A1 (de)
ZA (1) ZA200408281B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1791592B (zh) * 2003-05-19 2012-07-04 Irm责任有限公司 免疫抑制剂化合物和组合物
MY150088A (en) 2003-05-19 2013-11-29 Irm Llc Immunosuppressant compounds and compositions
ES2558761T3 (es) * 2003-05-19 2016-02-08 Novartis Ag Compuestos y composiciones inmunosupresores
EP1661881B1 (de) * 2003-08-29 2014-12-17 Ono Pharmaceutical Co., Ltd. Zur bindung an den s1p-rezeptor fähige verbindung und deren pharmazeutische verwendung
CN1874991A (zh) 2003-08-29 2006-12-06 小野药品工业株式会社 能够结合s1p受体的化合物及其药物用途
BRPI0415842A (pt) * 2003-10-23 2007-01-02 Hoffmann La Roche derivativos de benzapepina como inibidores de mao-b
PT1751111E (pt) 2004-03-01 2015-04-01 Actelion Pharmaceuticals Ltd Derivados de 1,2,3,4-tetrahidroisoquinolina substituída
EP2592066B1 (de) 2004-12-13 2014-12-03 Ono Pharmaceutical Co., Ltd. Aminocarboxylsäurederivate und medizinische Verwendung davon
WO2006079622A2 (de) * 2005-01-28 2006-08-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur herstellung von isochroman und derivaten davon
JP2008531509A (ja) 2005-02-25 2008-08-14 エフ．ホフマン−ラ ロシュ アーゲー 医薬品成分の改良された分散性を有する錠剤
EP1963280B1 (de) 2005-12-22 2015-10-28 Newron Pharmaceuticals S.p.A. 2-phenylethylaminoderivate als calcium- und/oder natrium-kanalmodulatoren
US20090082394A1 (en) * 2006-03-15 2009-03-26 Actelion Pharmaceuticals, Ltd. Tetrahydroisoquinoline Derivatives to Enhance Memory Function
ATE496051T1 (de) 2006-04-26 2011-02-15 Actelion Pharmaceuticals Ltd Pyrazolotetrahydropyridinderivate als orexinrezeptorantagonisten
KR101220182B1 (ko) * 2009-02-25 2013-01-11 에스케이바이오팜 주식회사 치환된 아졸 유도체 화합물, 이를 포함하는 약제학적 조성물 및 이를 이용한 파킨슨씨 병 치료방법
CN105315204B (zh) * 2014-07-04 2018-02-09 中南大学 7‑氨基‑1,4‑二氢异喹啉‑3(2h)‑酮衍生物及其合成方法和用途
CN105585527B (zh) * 2015-12-17 2018-06-26 浙江工业大学 2-(3,4-二氢异喹啉-1(2h)-亚基)乙腈类化合物及其应用
CN105461626B (zh) * 2015-12-17 2018-05-08 浙江工业大学 芳环或稠杂环联3,4-二氢异喹啉类共轭结构化合物及其应用
KR20190133714A (ko) * 2017-03-27 2019-12-03 브리스톨-마이어스 스큅 컴퍼니 면역조정제로서 유용한 치환된 이소퀴놀린 유도체
JP7720847B2 (ja) * 2019-12-18 2025-08-08 シーエイチディーアイ ファウンデーション，インコーポレーテッド ハンチンチンタンパク質をイメージングするための化合物及びプローブ
CN114591238B (zh) * 2022-03-25 2022-11-15 邦恩泰(山东)生物医药科技集团股份有限公司 一种异喹啉类药物中间体的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6137002A (en) * 1993-07-22 2000-10-24 Eli Lilly And Company Glycoprotein IIb/IIIa antagonists
US6448269B1 (en) * 1993-07-22 2002-09-10 Eli Lilly And Company Glycoprotein IIb/IIIa antagonists
US5731324A (en) * 1993-07-22 1998-03-24 Eli Lilly And Company Glycoprotein IIb/IIIa antagonists
IL110172A (en) * 1993-07-22 2001-10-31 Lilly Co Eli Bicyclic compounds and pharmaceutical compositions containing them
US5679715A (en) 1995-06-07 1997-10-21 Harris; Richard Y. Method for treating multiple sclerosis
EP0906090A1 (de) 1996-03-15 1999-04-07 Somerset Pharmaceuticals, Inc. Verfahren zur vorbeugung und behandlung von periphärer neuropathie
AU1359801A (en) 1999-11-05 2001-06-06 Vela Pharmaceuticals Inc. Methods and compositions for treating reward deficiency syndrome

Also Published As

Publication number Publication date
GT200300095A (es) 2004-01-15
CN1310890C (zh) 2007-04-18
RU2318812C2 (ru) 2008-03-10
WO2003091219A1 (en) 2003-11-06
PL373697A1 (en) 2005-09-05
EP1501804B1 (de) 2009-08-26
AR039651A1 (es) 2005-03-02
IL164677A0 (en) 2005-12-18
JP2005533761A (ja) 2005-11-10
ZA200408281B (en) 2005-10-14
CN1649844A (zh) 2005-08-03
KR20040104628A (ko) 2004-12-10
SI1501804T1 (sl) 2009-12-31
JP4322685B2 (ja) 2009-09-02
TW200307670A (en) 2003-12-16
PA8572001A1 (es) 2003-12-10
US20030225122A1 (en) 2003-12-04
TWI278451B (en) 2007-04-11
ES2329354T3 (es) 2009-11-25
DE60328978D1 (de) 2009-10-08
CA2483461A1 (en) 2003-11-06
MXPA04010537A (es) 2005-01-25
CA2483461C (en) 2010-12-21
US6818774B2 (en) 2004-11-16
MY133527A (en) 2007-11-30
EP1501804A1 (de) 2005-02-02
AU2003227614B2 (en) 2008-06-26
PE20040594A1 (es) 2004-08-30
PT1501804E (pt) 2009-10-29
DK1501804T3 (da) 2009-10-12
NZ535885A (en) 2007-05-31
RU2004134575A (ru) 2005-07-20
HK1080836A1 (en) 2006-05-04
UY27786A1 (es) 2003-10-31
NO20044571L (no) 2004-10-22
AU2003227614A1 (en) 2003-11-10
HRP20040952A2 (en) 2005-06-30
BR0309562A (pt) 2005-02-15
KR100681585B1 (ko) 2007-02-09

Similar Documents

Publication Publication Date Title
ATE452891T1 (de) Pyrimidopyrimidone als kinaseinhibitoren
ATE437862T1 (de) Pyrimidin-5-onderivate als ldl-pla2 inhibitoren
DE60325032D1 (de) 2-hydroxy-3-heteroarylindole derivate als gsk3 inhibitoren
ATE443054T1 (de) Cyano-pyrrolidine als dpp-iv inhibitoren
DE60320933D1 (de) Rho-kinase inhibitoren
DE60313872D1 (de) Pyrazoloä1,5-aüpyrimidine als hemmstoffe cyclin-abhängiger kinasen
ATE478870T1 (de) Spiroindolinpiperidinderivate
DK1556385T3 (da) Heterocyclocarboxamid-derivater
DE60330372D1 (de) Indol-3-schwefelderivate
ATE467631T1 (de) Chinuclidinamidderivate
ATE438644T1 (de) Chinazolinderivate
IS7720A (is) Píperidín-N-oxíð-afleiður
DK2248807T3 (da) N-Phenyl-2-pyrimidinaminderivater
DK1505963T3 (da) Hepatitis C-inhibitorer
DE50304983D1 (de) Heteroaryloxy-substituierte phenylaminopyrimidine als rho-kinaseinhibitoren
ATE437876T1 (de) Hexahydropyridoisochinoline als dpp-iv- inhibitoren
DE602004018837D1 (de) Ptidase-iv-inhibitoren
DE60315862D1 (de) Dihydropyridinonderivate als hne-inhibitoren
ATE529428T1 (de) Thioxanthinderivate als myeloperoxidaseinhibitoren
ATE440821T1 (de) Isochinolinderivate als mao-b inhibitoren
IS8180A (is) Nýjar besímídasólafleiður
ATE411306T1 (de) Biarylsulfonamide als mmp-inhibitoren
ATE402700T1 (de) Glycinamid-derivate als raf-kinase-hemmer
DE502004006055D1 (de) 6-arylamino-5-cyano-4-pyrimidinone als pde9a-inhibitoren
ATE335729T1 (de) 3h-chinazoline -4-on derivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1501804

Country of ref document: EP

REN Ceased due to non-payment of the annual fee